BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32620450)

  • 1. Cherubism: a systematic literature review of clinical and molecular aspects.
    Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
    Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic analysis of patients with cherubism.
    Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
    Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the SH3BP2 gene in 2 families of cherubism.
    Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
    Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
    Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
    Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
    Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
    BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic review.
    Kueper J; Tsimbal C; Olsen BR; Kaban L; Liao EC
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):54-61. PubMed ID: 33941395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.
    Sekerci AE; Balta B; Dundar M; Hu Y; Reichenberger EJ; Etoz OA; Nazlim S; Bayrakdar IS
    Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e340-4. PubMed ID: 24608212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
    Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
    J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
    Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
    Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
    Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
    Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
    Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
    Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
    Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
    Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cherubism in three siblings].
    Jákob N; Pintér GT; Kotmayer L; Nagy P; Bödör C; Barabás P; Bécser J; Szabó G; Bogdán S
    Orv Hetil; 2022 Mar; 163(11):446-452. PubMed ID: 35279646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in the SH3BP2 gene causes cherubism: case report.
    Li CY; Yu SF
    BMC Med Genet; 2006 Dec; 7():84. PubMed ID: 17147794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function.
    Mukherjee PM; Wang CJ; Chen IP; Jafarov T; Olsen BR; Ueki Y; Reichenberger EJ
    Am J Orthod Dentofacial Orthop; 2010 Aug; 138(2):140.e1-140.e11; discussion 140-1. PubMed ID: 20691350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
    Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
    Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.